We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type


Firm name


232 results found


Foley & Lardner LLP | USA | 21 Dec 2009

Antitrust issues in generic drug settlements: recent developments and considerations in where to draw a line

In the next few months, there will be new legislation (or, failing that, continued antitrust agency enforcement efforts) to restrict the use of litigation settlement agreements to resolve disputes between pharmaceutical industry IP rights holders and generic drug companies.


Wiley Rein LLP | USA | 5 Sep 2008

Congress considers legislation to toughen IP enforcement

Congress is considering several bills purporting to strengthen the rights and remedies available to copyright and trademark holders, and make it easier to prosecute repeat offenders by creating a new federal agency to oversee intellectual property enforcement.

Previous page 1 2 3 ...